COMMUNIQUÉS West-GlobeNewswire

Vystar Names Furniture Industry Leader Steve Rotman as CEO; Appoints 3 Board Members

20/12/2017 - 14:01

ATLANTA and WORCESTER, Mass., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Vystar Corporation (OCT Pink:VYST) today announced the appointment of Steven Rotman as its Chief Executive Officer and member of the Board of Directors, [...]

Clearside Biomedical, Inc. to Present at the 36th Annual J.P. Morgan Healthcare Conference

20/12/2017 - 14:00

ALPHARETTA, Ga., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, [...]

Eloxx Pharmaceuticals Completes Acquisition Transaction with Sevion Therapeutics

20/12/2017 - 14:00

WALTHAM, Mass. and REHOVOT, Israel and SAN DIEGO, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals Ltd. (“Eloxx”) and Sevion Therapeutics, Inc. (OTCQB:SVON) (“Sevion”) today announced the two companies have [...]

Aduro Biotech Expands Leading Intellectual Property Position in STING Field with Newly Issued Patent

20/12/2017 - 14:00

BERKELEY, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq: ADRO ), a biopharmaceutical company with three distinct immunotherapy technologies, today announced that the United States Patent and [...]

Precipio Launches Its Second New ICE-COLD PCR™ Targeted Enrichment Kit To Identify Mutations in Lung Cancer Using Liquid (Blood) Biopsies On Sanger Sequencing Platforms

20/12/2017 - 14:00

NEW HAVEN, Conn., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO ), announced today the launch of the second new version of its ICE-COLD PCR™ (ICP) enrichment kit, used to identify resistance mutations [...]

HTG Molecular Diagnostics to Participate in Corporate Access Event in San Francisco, January 8 – 10, 2018

20/12/2017 - 14:00

TUCSON, Ariz., Dec. 20, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (NASDAQ: HTGM ), a provider of instruments, reagents and services for molecular profiling applications, today announced that its senior [...]

R1 RCM to Present at the 36th Annual J.P. Morgan Healthcare Conference

20/12/2017 - 14:00

CHICAGO, Dec. 20, 2017 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM ), a leading provider of revenue cycle management services to healthcare providers, today announced its management team will present at the 36 th [...]

New Patent Issued to AMAG Pharmaceuticals Entitled "Methods of Reducing Risk of Preterm Birth"

20/12/2017 - 14:00

WALTHAM, Mass., Dec. 20, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today announced the issuance of U.S. Patent Number 9,844,558 entitled “Methods of Reducing Risk of Preterm Birth.” This newly [...]

Opiant Pharmaceuticals Announces Significant Financial Developments Related to NARCAN® Nasal Spray for Opioid Overdose

20/12/2017 - 14:00

Opiant Expects to Receive 90% of NARCAN Sales-Related Royalty and Milestone Payments, Going Forward SANTA MONICA, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT ), a [...]

Ovid Therapeutics Announces TAK-935/OV935 Granted Orphan Drug Designation by U.S. FDA for Treatment of Lennox-Gastaut Syndrome

20/12/2017 - 14:00

NEW YORK, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID ), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today [...]

Green Cures & Botanical Distribution, Inc. Appoints New CEO, Mr. William Pitsicalis

20/12/2017 - 14:00

LOS ANGELES, CA , Dec. 20, 2017 (GLOBE NEWSWIRE) -- Green Cures and Botanical Distribution Inc. (OTC PINK: GRCU), an innovative hemp-infused nutrition, botanical, sports, and body care products company, has appointed Mr [...]

IBEX Grants Stock Options and Amends Incentive Stock Option Plan

20/12/2017 - 14:00

MONTREAL, Dec. 20, 2017 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX-V: IBT ) announces that on December 19, 2017, its Board of Directors granted an aggregate of 675,000 stock options to [...]

AzurRx BioPharma Announces Publication of U.S. Patent Application for AZX1101

20/12/2017 - 13:30

BROOKLYN, N.Y., Dec. 20, 2017 (GLOBE NEWSWIRE) -- AzurRx BioPharma Inc.(NASDAQ: AZRX ) (“AzurRx” or the “Company”), today announced that the United States Patent and Trademark Office has published patent application [...]

New Member appointed to the Board of Directors of Neuralstem

20/12/2017 - 13:30

GERMANTOWN, Md., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq: CUR ), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that Xi Chen, Ph.D., has been [...]

Hemostemix Receives Health Canada Clearance to Continue with Critical Limb Ischemia Clinical Trials

20/12/2017 - 13:30

CALGARY, Alberta, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Hemostemix Inc . (“ Hemostemix ” or the “ Company ”) (TSX VENTURE:HEM) announced today that they have received a No Objection Letter from Health Canada for its current [...]

K2M Introduces World’s First 3D-Printed Expandable Corpectomy Cage with Cervical Spine Indications Following CE Mark of CAPRI® Cervical 3D Expandable Featuring Lamellar 3D Titanium Technology™

20/12/2017 - 13:01

LEESBURG, Va., Dec. 20, 2017 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]

Loxo Oncology Initiates Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Larotrectinib for the Treatment of TRK Fusion Cancers

20/12/2017 - 12:45

STAMFORD, Conn., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq: LOXO ), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers [...]

Avivagen Inc. Announces Results for Fiscal Year Ending October 31, 2017

20/12/2017 - 12:30

OTTAWA, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSX-V: VIV ) (OTC Pink:CHEXF) (“ Avivagen ” or the “ Company ”), a life sciences innovation company with a series of patent protected products that support and [...]

Achillion Initiates Phase I First-In Study of ACH-5228, a Next-Generation Oral Small Molecule Inhibitor of Complement Factor D

20/12/2017 - 12:05

NEW HAVEN, Conn., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN ), a pharmaceutical company focused on advancing small molecule inhibitors of factor D in the complement alternative [...]